Page last updated: 2024-09-02

florfenicol and imipenem, anhydrous

florfenicol has been researched along with imipenem, anhydrous in 2 studies

Compound Research Comparison

Studies
(florfenicol)
Trials
(florfenicol)
Recent Studies (post-2010)
(florfenicol)
Studies
(imipenem, anhydrous)
Trials
(imipenem, anhydrous)
Recent Studies (post-2010) (imipenem, anhydrous)
628704204,7843911,397

Protein Interaction Comparison

ProteinTaxonomyflorfenicol (IC50)imipenem, anhydrous (IC50)
Beta-lactamase Pseudomonas aeruginosa0.15

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Anderson, KC; Kellogg, GE; Sarkar, A1
Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y1

Other Studies

2 other study(ies) available for florfenicol and imipenem, anhydrous

ArticleYear
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
    European journal of medicinal chemistry, 2012, Volume: 52

    Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics

2012
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
    European journal of medicinal chemistry, 2022, Mar-05, Volume: 231

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests

2022